Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study - Concepedia

Concepedia

Publication | Open Access

Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study

DOI Full Paper Access

162

Citations

14

References

2015

Year

Jeffrey A. Cohen, Bhupendra Khatri, Frederik Barkhof, Giancarlo Comi, Hans-Peter Hartung, Xavier Montalbán, Jean Pelletier, Tracy Stites, Shannon Ritter, Philipp von Rosenstiel,

Journal of Neurology Neurosurgery & Psychiatry

Abstract

NCT00340834.

References

	Year	Citations

Page 1